rs7192711

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001009944.3(PKD1):​c.10822-14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00621 in 1,570,898 control chromosomes in the GnomAD database, including 483 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.032 ( 275 hom., cov: 33)
Exomes 𝑓: 0.0034 ( 208 hom. )

Consequence

PKD1
NM_001009944.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.405

Publications

3 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
PKD1-AS1 (HGNC:56035): (PKD1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 16-2093752-G-A is Benign according to our data. Variant chr16-2093752-G-A is described in ClinVar as Benign. ClinVar VariationId is 256896.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.108 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKD1NM_001009944.3 linkc.10822-14C>T intron_variant Intron 36 of 45 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkc.10822-14C>T intron_variant Intron 36 of 45 1 NM_001009944.3 ENSP00000262304.4

Frequencies

GnomAD3 genomes
AF:
0.0320
AC:
4864
AN:
152146
Hom.:
274
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.110
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0122
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000515
Gnomad OTH
AF:
0.0230
GnomAD2 exomes
AF:
0.00815
AC:
1467
AN:
179918
AF XY:
0.00640
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.00644
Gnomad ASJ exome
AF:
0.00572
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000677
Gnomad OTH exome
AF:
0.00623
GnomAD4 exome
AF:
0.00343
AC:
4865
AN:
1418634
Hom.:
208
Cov.:
32
AF XY:
0.00300
AC XY:
2107
AN XY:
702524
show subpopulations
African (AFR)
AF:
0.109
AC:
3539
AN:
32340
American (AMR)
AF:
0.00676
AC:
272
AN:
40252
Ashkenazi Jewish (ASJ)
AF:
0.00717
AC:
183
AN:
25508
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37332
South Asian (SAS)
AF:
0.000195
AC:
16
AN:
81938
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46526
Middle Eastern (MID)
AF:
0.00489
AC:
28
AN:
5726
European-Non Finnish (NFE)
AF:
0.000333
AC:
363
AN:
1090314
Other (OTH)
AF:
0.00790
AC:
464
AN:
58698
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
288
576
864
1152
1440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0321
AC:
4885
AN:
152264
Hom.:
275
Cov.:
33
AF XY:
0.0316
AC XY:
2356
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.110
AC:
4586
AN:
41520
American (AMR)
AF:
0.0122
AC:
186
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000515
AC:
35
AN:
68006
Other (OTH)
AF:
0.0227
AC:
48
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
232
464
697
929
1161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0127
Hom.:
86
Bravo
AF:
0.0363
Asia WGS
AF:
0.00433
AC:
16
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease, adult type Benign:1
Jan 28, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease Benign:1
-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PKD1 c.10822-14C>T variant was identified in 3 of 460 proband chromosomes (frequency: 0.007) from American individuals or families with ADPKD (Rossetti 2012). The variant was also identified in dbSNP (ID: rs7192711) as “With Benign allele”, the ADPKD Mutation Database (classification likely neutral), the 1000 Genomes Project in 165 of 5015 chromosomes (frequency: 0.03), HAPMAP-YRI in 26 of 226 chromosomes (frequency: 0.115), HAPMAP-ASW in 12 of 98 chromosomes (frequency: 0.122), HAPMAP-LWK in 22 of 189 chromosomes (frequency: 0.122), the NHLBI GO Exome Sequencing Project in 8 of 8552 European American alleles (frequency: 0.0009) and in 453 of 4362 African American alleles (frequency: 0.1), and in the Exome Aggregation Consortium database (August 8, 2016) in 531 of 33314 chromosomes (29 homozgyous) (frequency: 0.02) in the following populations: African in 466 (29 homozygotes) of 3264 chromosomes (frequency: 0.1), Latino in 31 of 2608 chromosomes (frequency: 0.01), Other in 2 of 280 chromosomes (frequency: 0.007), European (Non-Finnish) in 110 of 64720 chromosomes (frequency: 0.002), and South Asian in 1 of 9322 chromosomes (frequency: 0.0001), but was not seen in East Asian and Finnish and populations. The variant was also identified in Clinvitae (classification benign), ClinVar (classification benign, submitter Prevention Genetics), but was not in GeneInsight-COGR, PKD1-LOVD, and PKD1-LOVD 3.0. The variant was identified by our laboratory in 1 individual with ADPKD, co-occurring with a pathogenic PKD1 variant (c.12178C>T, p.Gln4060X), increasing the likelihood that the variant does not have clinical significance. The c.10822-14C>T variant is located in the 3' splice region but does not affect the invariant -1 and -2 positions. In addition, five of five in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a greater than 10% difference in splicing. In summary, based on the above information, this variant meets our laboratory criteria to be classified as benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
8.3
DANN
Benign
0.54
PhyloP100
0.41
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7192711; hg19: chr16-2143753; API